Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisphosphonate Effects on GCF Markers in Osteoporosis and Periodontitis
NCT04149405Phase 4Completed
- Sponsor
- Ondokuz Mayıs University
- Start
- Jun 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of zoledronic acid in postmenopausal osteoporosis, sponsored by Ondokuz Mayıs University. Started Jun 2016; status: completed.
02
Drugs
zoledronic acid
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT04149405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04149405.